Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918134 | Radiotherapy and Oncology | 2015 | 9 Pages |
Abstract
Crizotinib elicits beneficial effects in combination with radiotherapy only in ALK-positive NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ying Dai, Quanxiang Wei, Christian Schwager, Mahmoud Moustafa, Cheng Zhou, Kenneth E. Lipson, Wilko Weichert, Jürgen Debus, Amir Abdollahi,